|
27/04/2017 |
Hepatotoxicity by drugs |
CenQfal |
Registered |
|
27/03/2021 |
ABDALA-Intervention |
CIGB |
Registered |
|
27/01/2017 |
Pharmacovigilance-VALERGEN-Asthma |
BIOCEN |
Registered |
|
26/11/2020 |
ABDALA Clinical Study |
CIGB |
Registered |
|
26/11/2020 |
MAMBISA Study |
CIGB |
Registered |
|
26/08/2013 |
ior ®EPOCIM as a cardioprotective agent in the surgery of rheumatic valvular disease. |
CIMAB |
Registered outdated |
|
26/05/2014 |
Racotumomab,Nimotuzumab or Docetaxel in the treatment of the advanced non-small cell lung cancer. |
CIM |
Registered |
|
26/03/2021 |
Stem cell assisted centrifugal fat transfer |
HHA |
Registered |
|
26/03/2021 |
Itolizumab Safety and Efficacy Study in Covid 19 |
CIM |
Registered |
|
26/01/2017 |
ESAR-814 Study |
CIGB |
Registered |
|
25/09/2015 |
Seawater-Rhinitis-Children-Phase III |
UDEA |
Registered |
|
24/11/2020 |
Curmeric-Prevention-COVID-19-Health Workers-University Hospital General Calixto Garcia |
CEADEN |
Registered |
|
24/06/2015 |
SURFACEN in ARDS. Adults. Phase IV |
CENSA |
Registered |
|
23/12/2016 |
Itolizumab (T1h) combined with insulin in patients with Type I Diabetes Mellitus |
CIM |
Registered |
|
23/08/2019 |
Effect of beef consumption on lipid metabolism |
SSA |
Registered |
|
23/07/2021 |
SOBERANA CENTRO |
FINLAY |
Registered |
|
23/07/2021 |
SOBERANA PEDIATRIA CLINICA 1 |
FINLAY |
Registered |
|
23/05/2014 |
Phase II / III. Nimotuzumab in patients with triple-negative breast cancer. |
CIM |
Registered |
|
23/04/2014 |
CIGB-500 in acute myocardial infarction (AMIGOS study) |
CIGB |
Registered |
|
23/03/2020 |
EGF in bilateral symmetric diabetic neuropathy |
CIGB |
Registered |
